What is Eargo?
Headquartered in San Jose, California, Eargo specializes in the design and manufacture of virtually invisible, rechargeable hearing aids. By bypassing traditional clinical models, the company provides an accessible, high-quality alternative for individuals experiencing mild to moderate hearing loss. Eargo's market position is defined by its integration of mobile application technology with licensed professional support, effectively bridging the gap between medical-grade hearing solutions and consumer-friendly accessibility. The recent merger with hearX Group to form LXE Hearing further solidifies its footprint in the evolving over-the-counter hearing aid landscape.
How much funding has Eargo raised?
Eargo has raised a total of $506.4M across 9 funding rounds:
Series A
$13M
Series B
$25M
Private Equity
$32.4M
Series C
$45M
Series D
$52M
Multiple Rounds
$214M
Private Equity
$125M
Series A (2015): $13M with participation from Crosslink Capital, Maveron, Birchmere Ventures, and Dolby Family Ventures
Series B (2015): $25M led by New Enterprise Associates
Private Equity (2017): $32.4M supported by New Enterprise Associates
Series C (2017): $45M featuring New Enterprise Associates and Maveron
Series D (2019): $52M backed by Future Fund, Nan Fung Life Sciences, Maveron, New Enterprise Associates, and Charles and Helen Schwab Foundation
Debt (2020): $2M with participation from PPP
Series E (2020): $71M led by Gilde Healthcare company, Nan Fung Life Sciences, Helen Schwab Foundation, Longitude Capital, and New Enterprise Associates , Inc.
Stock Issuance/Offering (2020): $141M, investors not publicly disclosed
Private Equity (2022): $125M featuring Patient Square Capital
Key Investors in Eargo
New Enterprise Associates
Established in 1977 and headquartered in Menlo Park, California, New Enterprise Associates is a venture capital firm focused on helping entrepreneurs build businesses.
Patient Square Capital
Patient Square Capital is a specialized investment firm operating within the financial services sector, with a dedicated focus on the healthcare industry.
Maveron
Maveron is a consumer-only venture capital firm that partners with innovative entrepreneurs to transform consumer experiences and industries.
What's next for Eargo?
The recent strategic financing positions Eargo to accelerate its operational scale and deepen its penetration within the competitive hearing health market. By leveraging this capital, the company is expected to enhance its R&D capabilities, refine its direct-to-consumer distribution channels, and potentially expand its product portfolio. As the regulatory environment for over-the-counter hearing devices continues to evolve, Eargo's focus remains on maintaining its competitive edge through technological differentiation and strategic partnerships, ensuring long-term sustainability and improved patient outcomes in the global hearing care ecosystem.
See full Eargo company page
